Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.
Shuichi HironakaRyo SadachiNozomu MachidaSatoru IwasaYasuhide YamadaMitsuru SasakoTakaki YoshikawaNarikazu BokuMasanori TerashimaPublished in: Japanese journal of clinical oncology (2021)
Renal impairment was associated with severe adverse events in cisplatin plus S-1 therapy but not with the efficacy in cisplatin plus S-1 and docetaxel plus cisplatin plus S-1 therapy.